X0202 4 2007-01-09 1 0001138812 COTHERIX INC CTRX 0001257444 ALTA BIOPHARMA PARTNERS III LP ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 No longer 10% Owner 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001106287 GRUENER GARRETT ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001198328 MARDUEL ALIX ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001198330 NOHRA GUY P ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001276361 ALTA PARTNERS II INC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001211840 HURWITZ EDWARD ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001198332 PENHOET EDWARD ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner 0001341610 Alta Partners III, Inc. ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 0 1 Nolonger 10% Owner Common Stock 2007-01-09 4 D 0 1942611 13.50 D 0 I See footnotes Common Stock 2007-01-09 4 D 0 62226 13.50 D 0 I See footnotes Common Stock 2007-01-09 4 D 0 869164 13.50 D 0 I See footnotes Common Stock 2007-01-09 4 D 0 58370 13.50 D 0 I See footnotes Common Stock 2007-01-09 4 D 0 21415 13.50 D 0 I See footnotes Stock Option for Common Stock (right to buy) 0.54 2007-01-09 4 D 0 18180 13.50 D 2014-01-05 Common Stock 18180 0 D Stock Option for Common Stock (right to buy) 0.54 2007-01-09 4 D 0 6060 13.50 D 2014-01-05 Common Stock 6060 0 D Stock Option for Common Stock (right to buy) 2.18 2007-01-09 4 D 0 15150 13.50 D 2014-01-05 Common Stock 15150 0 D Stock Option for Common Stock (right to buy) 11.92 2007-01-09 4 D 0 6060 13.50 D 2015-01-02 Common Stock 6060 0 D Stock Option for Common Stock (right to buy) 10.58 2007-01-09 4 D 0 9090 13.50 D 2016-01-02 Common Stock 9090 0 D Stock Option for Common Stock (right to buy) 13.49 2007-01-09 4 D 0 9090 13.50 D 2017-01-02 Common Stock 9090 0 D Not applicable Alta California Partners III, L.P. ("ACPIII") disposed of 1,942,611 shares of Common Stock pursuant to a merger agreement between the Issuer and Actelion US Holding Company. Daniel Janney, Director, is a managing director of Alta California Management Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII") & a manager of Alta Embarcadero Partners III, LLC ("AEIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEIII. He is a member of Alta BioPharma Management III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of his proportionate pecuniary interests therein. Alta Partners II, Inc.& Alta Partners III, Inc. provide investment advisory services to several funds including ACPIII, AEIII, ABPIII, Alta BioPharma Partners III GmbH& Co. Beteiligungs KG ("ABPIIIKG") & Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The managing directors ("md") of ABMPIII (which is the gp of ABPIII & managing LP of ABPIIIKG), md of ACMPIII (which is GP of ACPIII) & managers of AEBIII & AEIII, exercise sole voting & investment powers with respect to the sh ("sh")owned by such funds. Gruener, Nohra & Janney (collectively known as the "principals") are md of ACMPIII& managers of AEPIII. Deleage, Champsi, Marduel, Hurwitz & Penhoet (collectively known as the "principals") are directors of ABMPIII & managers of AEBPIII, The principals may be deemed to share voting & investment powers over the sh held by the funds. The principals disclaim beneficial ownership of all such sh held by the funds, except to the extent of their porportionate pecuniary interest therein Alta Embarcadero Partners III, LLC disposed of 62,226 shares of Common Stock pursuant to the merger agreement between the Issuer and Actelion US Holding Company. Alta BioPharma Partners III, L.P. disposed of 869,164 shares of Common Stock pursuant to the merger agreement between the Issuer and Actelion US Holding Company. Alta BioPharma Partners III GmbH & Co. Beteligungs KG disposed of 58,370 shares of Common Stock pursuant to the merger between the Issuer and Actelion US Holding Company. Alta Embarcadero BioPharma Partners III, LLC disposed of 21,415 shares of Common Stock pursuant to the merger agreement between the Issuer and Actelion US Holding Company. This option held by Daniel Janney, which became fully vested on January 1, 2006, was canceled in the merger in exchange for a cash payment of $235,529.17, representing the difference between the exercise price of the option and merger consideration for the underlying common stock. The option held by Daniel Janney, which became fully vested January 1, 2005, was canceled in the merger in exchange for cash payment of $78,509.72, representing the difference between the exercise price of the option and the merger consideration for the underlying common stock. This option held by Daniel Janney, which became fully vested on January 1, 2006, was canceled in the merger in exchange for a cash payment of $171,525.27, representing the difference between the exercise price of the option and the merger consideration for the underlying common stock. This stock option held by Daniel Janney, which became fully vested January 1, 2006, was canceled in the merger in exchange for a cash payment of $9,574.80, representing the difference between the exercise price of the option and the merger consideration for the underlying common stock. This option held by Daniel Janney, which became fully vested on January 1, 2007, was canceled in the merger in exchange for cash payment of $26,542.80, representing the difference between the exercise price and the merger consideration for the underlying common stock. This stock option held by Daniel Janney, which became fully vested on January 1, 2007, was canceled in the merger in exchange for a cash payment of $90.90. representing the difference between the exercise price of the option and the merger consideration for the underlying common stock. Cross-reference to Form 4 for Daniel Janney filed on 01/09/2007. Farah Champsi, Director 2007-01-09 Farah Champsi 2007-01-09 Jean Deleage 2007-01-09 Garrett Gruener 2007-01-07 Alix Marduel 2007-01-09 Guy Nohra 2007-01-09 Jean Deleage, President 2007-01-09 Edward Hurwitz 2007-01-09 Edward Penhoet 2007-01-09 Jean Deleage, President 2007-01-09